Multimodal treatment of ADHD in the MTA: An alternative outcome analysis

C. Keith Conners, Jeffrey N. Epstein, John S. March, Adrian Angold, Karen C. Wells, John Klaric, James M. Swanson, L. Eugene Arnold, Howard B. Abikoff, Glen R. Elliott, Laurence L. Greenhill, Lily Hechtman, Stephen P. Hinshaw, Betsy Hoza, Peter S. Jensen, Helena C. Kraemer, Jeffrey H. Newcorn, William E. Pelham, Joanne B. Severe, Benedetto VitielloTimothy Wigal

Research output: Contribution to journalArticle

Abstract

Objective: To conduct a post hoc investigation of the utility of a single composite measure of treatment outcome for the NIMH Collaborative Multisite Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder (MTA) at 14 months postbaseline. Background: Examination of multiple measures one at a time in the main MTA intent-to-treat outcome analyses failed to detect a statistically significant advantage of combined treatment (Comb) over medication management (MedMgt). A measure that increases power and precision using a single outcome score may be a useful alternative to multiple outcome measures. Method: Factor analysis of baseline scores yielded two "source factors" (parent and teacher) and one "instrument factor" (parent-child interactions). A composite score was created from the average of standardized parent and teacher measures. Results: The composite was internally consistent (α = .83), reliable (test-retest over 3 months = 0.86), and correlated 0.61 with clinician global judgments. In an intent-to-treat analysis, Comb was statistically significantly better than all other treatments, with effect sizes ranging from small (0.28) versus MedMgt, to moderately large (0.70) versus a community comparison group. Conclusions: A composite of ADHD variables may be an important tool in future treatment trials with ADHD and may avoid some of the statistical limitations of multiple measures.

Original languageEnglish (US)
Pages (from-to)159-167
Number of pages9
JournalJournal of the American Academy of Child and Adolescent Psychiatry
Volume40
Issue number2
StatePublished - 2001
Externally publishedYes

Fingerprint

Pemetrexed
Combined Modality Therapy
National Institute of Mental Health (U.S.)
Therapeutics
Attention Deficit Disorder with Hyperactivity
Statistical Factor Analysis
Outcome Assessment (Health Care)

Keywords

  • Attention-deficit/hyperactivity disorder
  • Clinical trial
  • Composite
  • NIMH collaborative Multisite Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Developmental and Educational Psychology

Cite this

Conners, C. K., Epstein, J. N., March, J. S., Angold, A., Wells, K. C., Klaric, J., ... Wigal, T. (2001). Multimodal treatment of ADHD in the MTA: An alternative outcome analysis. Journal of the American Academy of Child and Adolescent Psychiatry, 40(2), 159-167.

Multimodal treatment of ADHD in the MTA : An alternative outcome analysis. / Conners, C. Keith; Epstein, Jeffrey N.; March, John S.; Angold, Adrian; Wells, Karen C.; Klaric, John; Swanson, James M.; Arnold, L. Eugene; Abikoff, Howard B.; Elliott, Glen R.; Greenhill, Laurence L.; Hechtman, Lily; Hinshaw, Stephen P.; Hoza, Betsy; Jensen, Peter S.; Kraemer, Helena C.; Newcorn, Jeffrey H.; Pelham, William E.; Severe, Joanne B.; Vitiello, Benedetto; Wigal, Timothy.

In: Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 40, No. 2, 2001, p. 159-167.

Research output: Contribution to journalArticle

Conners, CK, Epstein, JN, March, JS, Angold, A, Wells, KC, Klaric, J, Swanson, JM, Arnold, LE, Abikoff, HB, Elliott, GR, Greenhill, LL, Hechtman, L, Hinshaw, SP, Hoza, B, Jensen, PS, Kraemer, HC, Newcorn, JH, Pelham, WE, Severe, JB, Vitiello, B & Wigal, T 2001, 'Multimodal treatment of ADHD in the MTA: An alternative outcome analysis', Journal of the American Academy of Child and Adolescent Psychiatry, vol. 40, no. 2, pp. 159-167.
Conners CK, Epstein JN, March JS, Angold A, Wells KC, Klaric J et al. Multimodal treatment of ADHD in the MTA: An alternative outcome analysis. Journal of the American Academy of Child and Adolescent Psychiatry. 2001;40(2):159-167.
Conners, C. Keith ; Epstein, Jeffrey N. ; March, John S. ; Angold, Adrian ; Wells, Karen C. ; Klaric, John ; Swanson, James M. ; Arnold, L. Eugene ; Abikoff, Howard B. ; Elliott, Glen R. ; Greenhill, Laurence L. ; Hechtman, Lily ; Hinshaw, Stephen P. ; Hoza, Betsy ; Jensen, Peter S. ; Kraemer, Helena C. ; Newcorn, Jeffrey H. ; Pelham, William E. ; Severe, Joanne B. ; Vitiello, Benedetto ; Wigal, Timothy. / Multimodal treatment of ADHD in the MTA : An alternative outcome analysis. In: Journal of the American Academy of Child and Adolescent Psychiatry. 2001 ; Vol. 40, No. 2. pp. 159-167.
@article{e14422fa9c1b492cb56518291b10be17,
title = "Multimodal treatment of ADHD in the MTA: An alternative outcome analysis",
abstract = "Objective: To conduct a post hoc investigation of the utility of a single composite measure of treatment outcome for the NIMH Collaborative Multisite Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder (MTA) at 14 months postbaseline. Background: Examination of multiple measures one at a time in the main MTA intent-to-treat outcome analyses failed to detect a statistically significant advantage of combined treatment (Comb) over medication management (MedMgt). A measure that increases power and precision using a single outcome score may be a useful alternative to multiple outcome measures. Method: Factor analysis of baseline scores yielded two {"}source factors{"} (parent and teacher) and one {"}instrument factor{"} (parent-child interactions). A composite score was created from the average of standardized parent and teacher measures. Results: The composite was internally consistent (α = .83), reliable (test-retest over 3 months = 0.86), and correlated 0.61 with clinician global judgments. In an intent-to-treat analysis, Comb was statistically significantly better than all other treatments, with effect sizes ranging from small (0.28) versus MedMgt, to moderately large (0.70) versus a community comparison group. Conclusions: A composite of ADHD variables may be an important tool in future treatment trials with ADHD and may avoid some of the statistical limitations of multiple measures.",
keywords = "Attention-deficit/hyperactivity disorder, Clinical trial, Composite, NIMH collaborative Multisite Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder",
author = "Conners, {C. Keith} and Epstein, {Jeffrey N.} and March, {John S.} and Adrian Angold and Wells, {Karen C.} and John Klaric and Swanson, {James M.} and Arnold, {L. Eugene} and Abikoff, {Howard B.} and Elliott, {Glen R.} and Greenhill, {Laurence L.} and Lily Hechtman and Hinshaw, {Stephen P.} and Betsy Hoza and Jensen, {Peter S.} and Kraemer, {Helena C.} and Newcorn, {Jeffrey H.} and Pelham, {William E.} and Severe, {Joanne B.} and Benedetto Vitiello and Timothy Wigal",
year = "2001",
language = "English (US)",
volume = "40",
pages = "159--167",
journal = "Journal of the American Academy of Child and Adolescent Psychiatry",
issn = "0890-8567",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Multimodal treatment of ADHD in the MTA

T2 - An alternative outcome analysis

AU - Conners, C. Keith

AU - Epstein, Jeffrey N.

AU - March, John S.

AU - Angold, Adrian

AU - Wells, Karen C.

AU - Klaric, John

AU - Swanson, James M.

AU - Arnold, L. Eugene

AU - Abikoff, Howard B.

AU - Elliott, Glen R.

AU - Greenhill, Laurence L.

AU - Hechtman, Lily

AU - Hinshaw, Stephen P.

AU - Hoza, Betsy

AU - Jensen, Peter S.

AU - Kraemer, Helena C.

AU - Newcorn, Jeffrey H.

AU - Pelham, William E.

AU - Severe, Joanne B.

AU - Vitiello, Benedetto

AU - Wigal, Timothy

PY - 2001

Y1 - 2001

N2 - Objective: To conduct a post hoc investigation of the utility of a single composite measure of treatment outcome for the NIMH Collaborative Multisite Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder (MTA) at 14 months postbaseline. Background: Examination of multiple measures one at a time in the main MTA intent-to-treat outcome analyses failed to detect a statistically significant advantage of combined treatment (Comb) over medication management (MedMgt). A measure that increases power and precision using a single outcome score may be a useful alternative to multiple outcome measures. Method: Factor analysis of baseline scores yielded two "source factors" (parent and teacher) and one "instrument factor" (parent-child interactions). A composite score was created from the average of standardized parent and teacher measures. Results: The composite was internally consistent (α = .83), reliable (test-retest over 3 months = 0.86), and correlated 0.61 with clinician global judgments. In an intent-to-treat analysis, Comb was statistically significantly better than all other treatments, with effect sizes ranging from small (0.28) versus MedMgt, to moderately large (0.70) versus a community comparison group. Conclusions: A composite of ADHD variables may be an important tool in future treatment trials with ADHD and may avoid some of the statistical limitations of multiple measures.

AB - Objective: To conduct a post hoc investigation of the utility of a single composite measure of treatment outcome for the NIMH Collaborative Multisite Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder (MTA) at 14 months postbaseline. Background: Examination of multiple measures one at a time in the main MTA intent-to-treat outcome analyses failed to detect a statistically significant advantage of combined treatment (Comb) over medication management (MedMgt). A measure that increases power and precision using a single outcome score may be a useful alternative to multiple outcome measures. Method: Factor analysis of baseline scores yielded two "source factors" (parent and teacher) and one "instrument factor" (parent-child interactions). A composite score was created from the average of standardized parent and teacher measures. Results: The composite was internally consistent (α = .83), reliable (test-retest over 3 months = 0.86), and correlated 0.61 with clinician global judgments. In an intent-to-treat analysis, Comb was statistically significantly better than all other treatments, with effect sizes ranging from small (0.28) versus MedMgt, to moderately large (0.70) versus a community comparison group. Conclusions: A composite of ADHD variables may be an important tool in future treatment trials with ADHD and may avoid some of the statistical limitations of multiple measures.

KW - Attention-deficit/hyperactivity disorder

KW - Clinical trial

KW - Composite

KW - NIMH collaborative Multisite Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder

UR - http://www.scopus.com/inward/record.url?scp=0035144679&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035144679&partnerID=8YFLogxK

M3 - Article

C2 - 11211364

AN - SCOPUS:0035144679

VL - 40

SP - 159

EP - 167

JO - Journal of the American Academy of Child and Adolescent Psychiatry

JF - Journal of the American Academy of Child and Adolescent Psychiatry

SN - 0890-8567

IS - 2

ER -